The Research Group of Immunology and Rheumatology is divided into three labs and a research school:
Our group members have a mutual interest in translational research on chronic inflammatory and autoimmune diseases. Research performed spans from molecular and genetic studies, cellular studies and experimental models and studies on clinically well-characterized patient samples. Our ambition is to understand the molecular mechanisms active in different diseases and their subgroups, the underlying risk factors and triggers. We believe this paves the way for better, personalized treatment and ultimately to prevention of disease. We collaborate closely with clinicians and scientists at Haukeland hospital, within Norway, across Scandinavia and worldwide. We are also hosting the Bergen Research School in Inflammation.
BEaBiRD, Bergen group of Epidemiology and Biomarkers in Rheumatic disease, is a research group located at the Department of Rheumatology, Haukeland University Hospital. BEaBiRD has two major research areas. Firstly, we study epidemiology and long-term outcome of rheumatic disease and osteoporosis using disease-specific function-related outcomes, as well as complications, joint surgery, cardiovascular disease and death. Secondly, we study biomarkers in rheumatic disease investigating serological, cellular and intracellular biomarkers in patients with inflammatory joint disease and osteoporosis.
The Bergen Research School in Inflammation (BRSI) is a multidisciplinary research school covering basic, translational and clinical research training at both the University of Bergen and Haukeland University Hospital. BRSI was formally established in 2005 as the first research school at the Medical Faculty and one of the first at the University of Bergen. We chose a more pragmatic approach when starting our research school with support from the Broegelmann Research Laboratory. Since then we have developed into a strong and focused training unit with regular course activities at least twice a week.